Loading...

⚠ โœ•
❮ Top
☎ Help
Draft upto 3 replies to a
tax notice โ€” FREE ๐ŸŽ‰ โœ•

150 credits ยท 30 days

โ€ข Basic Search โ†’ 1 Credit
โ€ข Advanced Search โ†’ 3 Credits
โ€ข Drafter โ†’ 20 to extract + 25 per issue
(โ‰ˆ upto 2-3 drafts on us)

Already used our earlier 20-Credit Demo?
You are still eligible for this new 150-Credit Demo.

Activate your FREE Demo โ†’
☰
×

By creating an account you can:

Logo TaxTMI
Call Us / Help / Feedbackโœ•

Contact Us At :

✉ E-mail: [email protected]

✆ Call / WhatsApp at: +91 99117 96707

For more information, Check Contact Us

FAQs :

To know Frequently Asked Questions, Check FAQs

Most Asked Video Tutorials :

For more tutorials, Check Video Tutorials

Submit Feedback/Suggestion :

Email :
Please provide your email address so we can follow up on your feedback.
Category :
Description :
Min 15 characters 0/2000
TMI Blog
Home / TMI Blogs / RSS

2017 (4) TMI 211

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

.... Shri R.K. Manjhi, DR, for the Appellant. Shri B.L. Narsimhan, Advocate, for the Respondent. ORDER [Order per : B. Ravichandran, Member (T)] : - The Revenue is in appeal against 2 impugned orders passed by Commissioner (Appeals), Indore. The dispute in the present appeals is that the bulk drug 4 Hydroxy 7 Chloroqununoline, emerging as an intermediate product in the manufacture of final p....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....ned order dropped the demand on two grounds. One is the marketability of the product was held to be not established by the Revenue and second in any case the intermediate product used within the factory or production for manufacture of drug are wholly exempt with effect from 1-3-2003 by virtue of amended Notification 6/2003-C.E. 4. We have heard both the sides and perused the records. 5....